Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets

Diagnostic Molecular Pathology

Volumn 15, Issue 4, 2006, Pages 195-205

  Van Meter, Timothy ^a,b   Dumur, Catherine ^a   Hafez, Naiel ^a   Garrett, Carleton ^a   Fillmore, Helen ^a   Broaddus, William C ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Glioblastoma; Heterogeneity; Microarray; MRI; Therapeutic target

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; INTERSTITIAL COLLAGENASE; RNA; VASCULOTROPIN A;

ALGORITHM; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; DRUG TARGETING; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALGORITHMS; BIOPSY; BLOTTING, WESTERN; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STEREOTAXIC TECHNIQUES;

EID: 33751359631     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pdm.0000213464.06387.36     Document Type: Article

References (39)

1. Frederick L, Wang XY, Eley G, et al. Diversity frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 2000;60:1383-1387.
2. Cheng Y, Ng HK, Ding M, et al. Molecular analysis of microdissected de novo glioblastomas paired astrocytic tumors. J Neuropathol Exp Neurol. 1999;58:120-128.
3. Okada Y, Hurwitz EE, Esposito JM, et al. Selection pressures of TP53 mutation microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res. 2003;63:413-416.
4. Mariani L, Beaudry C, McDonough WS, et al. Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res. 2001;7:2480-2489.
5. Hoelzinger DB, Mariani L, Weis J, et al. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia. 2005;7:7-16.
6. Suzuki T, Maruno M, Wada K, et al. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor Pathol. 2004;21:27-34.
7. Dumur CI, Nasim S, Best AM, et al. Evaluation of quality-control criteria for microarray gene expression analysis. Clin Chem. 2004;50:1994-2002.
8. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
9. Huntington JT, Shields JM, Der CJ, et al. Over-expression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling. J Biol Chem. 2004;279:33168-33176.
10. Connolly JM, Rose DP. Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice. J Urol. 1998;160:932-936.
11. Gagnon V, Mathieu I, Sexton E, et al. AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecol Oncol. 2004;94:785-795.
12. Gordon MS, Margolin K, Talpaz M, et al. Phase I safety pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol. 2001;19:843-850.
13. Winkler F, Kozin SV, Tong RT, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation angiopoietin-1, matrix metalloproteinases. Cancer Cell. 2004;6:553-563.
14. Jayson GC, Mulatero C, Ranson M, et al. European Organisation for Research and Treatment of Cancer (EORTC). Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer. Eur J Cancer. 2005;41:555-563.
15. Van Meter TE, Rooprai HK, Kibble MM, et al. The role of matrix metalloproteinase genes in glioma invasion: co-dependent interactive proteolysis. J Neurooncol. 2001;53:213-235.
16. Tatton WG, Chalmers-Redman RM, Ju WJ, et al. Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther. 2002;301:753-764.
17. Gasparian AV, Yao YJ, Kowalczyk D, et al. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J Cell Sci. 2002;115:141-151.
18. Nomura M, Yamagishi S, Harada S, et al. Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neuro-oncol. 1998;40:123-130.
19. Hatva E, Kaipainen A, Mentula P, et al. Expression of endothelial cell-specific receptor tyrosine kinases growth factors in human brain tumors. Am J Pathol. 1995;146:368-378.
20. Rooprai HK, Vanmeter T, Panou C, et al. The role of integrin receptors in aspects of glioma invasion in vitro. Int J Dev Neurosci. 1999;17:613-623.
21. Calderwood DA, Fujioka Y, de Pereda JM, et al. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci USA. 2003;100:2272-2277.
22. Berditchevski F, Zutter MM, Hemler ME. Characterization of novel complexes on the cell surface between integrins proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell. 1996;7:193-207.
23. Arnaout MA. Integrin structure: new twists turns in dynamic cell adhesion. Immunol Rev. 2002;186:125-140.
24. Takagi J, Petre BM, Walz T, et al. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 2002;110:599-611.
25. Hashimoto S, Tsubouchi A, Mazaki Y, et al. Interaction of paxillin with p21-activated Kinase (PAK). Association of paxillin alpha with the kinase-inactive and the Cdc42-activated forms of PAK3. J Biol Chem. 2001;276:6037-6045.
26. Vijayan KV, Liu Y, Dong JF, et al. Enhanced activation of mitogen-activated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin beta 3. J Biol Chem. 2003;278:3860-3867.
27. VanMeter T, Dumur C, Hafez H, et al. Intratumoral heterogeneity in glioblastoma: up-regulation of invasion-related genes in perinecrotic tissue. Neuro-Oncology. 2004;6:340; Abstract.
28. Tropepe V, Sibilia M, Ciruna BG, et al. Distinct neural stem cells proliferate in response to EGF FGF in the developing mouse telencephalon. Dev Biol. 1999;208:166-188.
29. Kuhn HG, Winkler J, Kempermann G, et al. Epidermal growth factor fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci. 1997;17:5820-5829.
30. Van Meter TE, Broaddus WC, Rooprai HK, et al. Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. Neuro-Oncology. 2004;6:188-199.
31. Lal A, Glazer CA, Martinson HM, et al. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res. 2002;62:3335-3339.
32. Kim S, Dougherty ER, Shmulevich I, et al. Identification of combination gene sets for glioma classification. Mol Cancer Ther. 2002;1:1229-1236.
33. Raza SM, Fuller GN, Rhee CH, et al. Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res. 2004;10:212-221.
34. Affymetrix GeneChips. Expression Analysis Technical Manual. Santa Clava, CA: Affymetrix; 2001.
35. Sugita M, Geraci M, Gao B, et al. Combined use of oligonucleotide tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res. 2002;62:3971-3979.
36. Irizarry RA, Bolstad BM, Collin F, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
37. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: model validation design issues standard error application. Genome Biol. 2001;2:RESEARCH0032.
38. Hubbell E, Liu W-M, Mei R. Robust estimators for expression analysis. Bioinformatics. 2002;18:1585-1592.
39. Zhang L, Wang L, Ravindranathan A, et al. A new algorithm for analysis of oligonucleotide arrays: application to expression profiling in mouse brain regions. J Mol Biol. 2002;317:225-235.